Allogene Therapeutics, Inc. entered into lease agreement to expand its headquarters in South San Francisco, California. The lease is expected to commence on April 1, 2022, and the additional 47,566 square feet of office and laboratory space will support the growth of its research platform and correlative clinical development activities. With this lease the company will occupy over 100,000 square feet at its headquarters in South San Francisco. In addition, the company has built Cell Forge 1, a cell therapy manufacturing facility in Newark, CA.